INO-3107 With Electroporation (EP) in Participants With HPV-6- and/or HPV-11-Associated Recurrent Respiratory Papillomatosis (RRP)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jeffrey Skolnik, MD
Inovio Pharmaceuticals
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic Arizona
Phoenix, Arizona, United States
- University of California at Davis
Sacramento, California, United States
- Winship at Emory University Hospital Midtown
Atlanta, Georgia, United States
- Johns Hopkins University School of Medicine
Baltimore, Maryland, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Nyu Langone Voice Center
New York, New York, United States
- Unc School of Medicine
Chapel Hill, North Carolina, United States
- Cincinnati Children'S Hospital
Cincinnati, Ohio, United States
- University of Cincinnati Medical Center
Cincinnati, Ohio, United States
- Ut Southwestern Medical Center
Dallas, Texas, United States
- Baylor College of Medicine
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 7 Oct 2020
- Primary completion
- 15 Dec 2022
- Completion
- 15 Dec 2022
- Last update posted
- 14 Apr 2026
- Registered enrollment
- 32
- Registry id
- NCT04398433
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.